Research - News
UAB’s School of Engineering continues to move forward with development of personal protective equipment.
Gender identity and genetic sex are distinctly variable when it comes to pain tolerance, according to a study published in the Journal of Pain Research.
Model building and analysis of optically controlled quantum computation at UAB leads to new discovery.
UAB researchers have quickly developed and launched multiple research studies geared at treating or preventing COVID-19, following generous funding support from the Birmingham community.
The ranking measured 79 anatomy/cell biology departments in U.S. medical schools.
The work centers around ReFRAME, a vast collection of drugs developed for other diseases that are already known to be safe for humans.
Such competitive awards demonstrate that UAB provides students “an exceptionally strong foundation for research success.”
The goal is material that approaches a diamond in hardness and can survive extreme pressure, temperature and corrosive environments.
UAB’s School of Engineering produces face shield prototype to assist with PPE shortage due to the coronavirus.
A UAB School of Optometry professor has received an R01 grant from the NIH to study age-related cataracts, with hopes to slow their progression.
UAB Biomedical Engineering brings in more NIH funding do than regional peers like Vanderbilt, Duke and others, according to data from the Blue Ridge Institute.
iNO has been used for the treatment of failing lungs, but it was also found to have antiviral properties against coronaviruses.
UAB expert Gary Warner and UAB Information Technology provide tips on how to protect yourself from cybercrime during the coronavirus pandemic.
This discovery has implications in cancer, stem cell growth, and blood or neuron progenitor cell speciation.
The testing at UAB will investigate immune responses to the vaccine in mice — an important step before any Phase 1 human safety trial in patients later this year.

UAB is playing a key role in the effort to expedite clinical trials to combat COVID-19.

Francis Collins, M.D., Ph.D., visited UAB just as COVID-19 appeared near the NIH.

The study showed that 7.4 percent of veterans with a history of homelessness reported having an overdose in the past 3 years. Alcohol was the most commonly involved substance, but opioids and other drugs were common.

UAB researchers are now running tests and will soon have them available on a commercial platform, increasing output.

An immune reaction to COVID-19 infection called cytokine storm syndrome can be fatal to COVID-19 patients.

The study observed two diet types to test their impact on adolescents with non-alcoholic fatty liver disease.
In the first study of its kind, researchers identified genetic factors that can lead to a decrease in cognitive ability after a blood or bone marrow transplant.
The study uncovered bias and stereotyping when recruiting patients for clinical trials.

The tuberculosis bacteria induce increased hydrogen sulfide production by human macrophages, which increases pathogenesis.

Manipulating cellular metabolism may provide a promising therapeutic intervention in autoimmune diseases.
Telecommunicator CPR, guidance and assistance from 911 dispatchers can help 911 callers save lives.
This suggests the possibility of cross-talk that heightens pathogenesis in Type 1 diabetes.
People who spent their childhood or early adulthood in the Stroke Belt are more likely to develop cognitive impairment later, even if they have moved away.
New guidelines for operating room attire to prevent surgical site infections may be ineffective.
Influenza NS1 can bind with the cell’s RIG-I protein, blocking the innate immune response
Page 4 of 47